Optimized epicutaneous vaccination
US11938178B2 · kind B2 · utility
0Cited by
1References
21Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | Jul 9, 2019 |
| Grant date | Mar 26, 2024 |
| Priority date | — |
| Expiry date | Jul 9, 2039 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61M2037/0046
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention relates to improved epicutaneous administration methods for vaccination of a subject. In particular, the present invention discloses the use of an antigen for epicutaneous immunization, wherein the antigen is administered by epicutaneous application with a skin patch device in combination with an epidermal skin treatment.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.